M&A Deal Summary

Phibro Acquires Zoetis Medicated Feed Additive Portfolio

On April 28, 2024, Phibro acquired consumer products company Zoetis Medicated Feed Additive Portfolio from Zoetis for 350M USD

Acquisition Highlights
  • This is Phibro’s 3rd transaction in the Consumer Products sector.
  • This is Phibro’s largest (disclosed) transaction.
  • This is Phibro’s 3rd transaction in the United States.
  • This is Phibro’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2024-04-28
Target Zoetis Medicated Feed Additive Portfolio
Sector Consumer Products
Buyer(s) Phibro
Sellers(s) Zoetis
Deal Type Divestiture
Deal Value 350M USD

Target

Zoetis Medicated Feed Additive Portfolio

Parsippany, New Jersey, United States
Zoetis Medicated Feed Additive Portfolio comprises more than 37 product lines across cattle, swine, and poultry with six manufacturing sites, four in the U.S., one in Italy, and one in China.

Search 193,605 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Phibro

Teaneck, New Jersey, United States

website

Category Company
Founded 2014
Sector Food
Employees1,700
Revenue 800M USD (2020)
DESCRIPTION

Phibro is a global diversified animal health and mineral nutrition company. Phibro develops, manufactures and markets a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. Phibro's products help prevent, control and treat diseases, enhance nutrition to help improve health and contribute to balanced mineral nutrition. Phibro was founded in 2014 and is based in Teaneck, New Jersey.

DEAL STATS #
Overall 5 of 5
Sector (Consumer Products) 3 of 3
Type (Divestiture) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 3 of 3
Year (2024) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-08-01 Osprey Biotechnics

Sarasota, Florida, United States

Osprey Biotechnics, Inc. is a privately-held developer and marketer of innovative microbial products. Osprey manufacturers and markets numerous products for a variety of applications and industries. Osprey also produces the key components for Phibro’s recently launched Provia Prime direct-fed microbial product for poultry.

Buy -

Seller(S) 1

SELLER

Zoetis

Parsippany, New Jersey, United States

website

Category Company
Founded 1952
Sector Life Science
Employees11,300
Revenue 6.7B USD (2020)
DESCRIPTION

Zoetis engages in the discovery, development, manufacture and commercialization of a diverse portfolio of animal health medicines and vaccines designed to meet the real-world needs of veterinarians and the livestock farmers and companion animal owners they support. Zoetis was founded in 1952 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 2 of 2
Sector (Consumer Products) 1 of 1
Type (Divestiture) 2 of 2
State (New Jersey) 1 of 1
Country (United States) 2 of 2
Year (2024) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-05-16 Pumpkin

New York, New York, United States

Pumpkin is a provider of preventive care and pet insurance founded to help ensure pets live their longest and healthiest lives. The company plans offer dog and cat owners advanced veterinary care coverage for accidents and illnesses, and their optional Preventive Essentials non-insurance add-on offers life-threatening disease prevention through reimbursing for vaccines and the related annual wellness exam and lab tests, helping enable consumers to make data-informed care decisions based upon their individual pet's health needs. All pet insurance plans offered by Pumpkin provide reimbursement for covered care administered by any licensed veterinary clinic in the U.S. and Canada. Pumpkin is based in New York, New York.

Sell -
Mergr

Product

Company

Legal